Equitable Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $996K | Buy |
2,237
+85
| +4% | +$37.8K | 0.01% | 797 |
|
|
2025
Q1 | $1.04M | Buy |
2,152
+415
| +24% | +$201K | 0.01% | 698 |
|
|
2024
Q4 | $699K | Sell |
1,737
-220
| -11% | -$88.6K | 0.01% | 773 |
|
|
2024
Q3 | $910K | Buy |
1,957
+318
| +19% | +$148K | 0.01% | 699 |
|
|
2024
Q2 | $768K | Buy |
1,639
+147
| +10% | +$68.9K | 0.01% | 710 |
|
|
2024
Q1 | $624K | Buy |
1,492
+85
| +6% | +$35.5K | 0.01% | 737 |
|
|
2023
Q4 | $573K | Buy |
1,407
+41
| +3% | +$16.7K | 0.01% | 728 |
|
|
2023
Q3 | $475K | Buy |
1,366
+30
| +2% | +$10.4K | 0.01% | 732 |
|
|
2023
Q2 | $470K | Sell |
1,336
-178
| -12% | -$62.6K | 0.01% | 720 |
|
|
2023
Q1 | $477K | Buy |
1,514
+721
| +91% | +$227K | 0.01% | 663 |
|
|
2022
Q4 | $229K | Buy |
+793
| New | +$229K | ﹤0.01% | 814 |
|
|
2020
Q4 | – | Sell |
-1,791
| Closed | -$487K | – | 704 |
|
|
2020
Q3 | $487K | Buy |
1,791
+19
| +1% | +$5.17K | 0.01% | 426 |
|
|
2020
Q2 | $514K | Buy |
+1,772
| New | +$514K | 0.01% | 397 |
|